Jump to content

Xu Jingren

Edit links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Bender the Bot (talk | contribs) at 12:05, 3 August 2020 (→‎Family: HTTP → HTTPS for CNN Money, replaced: =http://money.cnn.com/ → =https://money.cnn.com/). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Template:Chinese name

Xu Jingren
徐镜人
Born1944 (age 79–80)
Taizhou, Jiangsu, China
EducationB.A.
Occupation(s)Pharmaceutical executive, philanthropist
Children2

Xu Jingren (Chinese: 徐镜人; born 1944) is the chairman and president of Yangtze River Pharmaceutical Group,[2] National People's Congress delegate and honorary vice-minister in China's Ministry of Health. Xu has been an outspoken research leader in China, where he has frequently called for labor reform and business regulation.[3] As of 2018, his estimated net worth is USD$4.6 billion,[4] one of four family members to be listed among the world's wealthiest.

Family

The family were noted victims of the 2015 Chinese stock market crash, during which they lost approximately 40% of their previously estimated USD$8 billion combined net worth.[5] Despite this, Xu Jingren and his relatives continue to be mentioned as one of China's top "vampire billionaire" families with majority investments abroad.[6][7][8] Notable international initiatives include the 2017 YRPG subsidiary[9] merger and rebranding of global drug manufacturer ShangPharma[10] by group CEO Michael Hui and board vice-chair Aaron Shang, with a stated intent of expanding North American operations leading to development of San Francisco-based venture portfolio ShangPharma Innovation.[11][12][13]


References

  1. ^ "Xu Jingren". Forbes.com. Retrieved 5 October 2018.
  2. ^ "Company Overview of Jiangsu Yangtze River Pharmaceutical Group Company Ltd". Bloomberg.com/. Bloomberg Business.
  3. ^ "Deputy: cost cutting affects public health". Npc.gov.cn. NPC.
  4. ^ "Xu Jingren Net Worth". Forbes.com. Forbes Magazine.
  5. ^ "China's Richest Billionaires Lost $195 Billion In One Month Amid Stock Market Rout". Forbes.com. Forbes Investing. Retrieved 22 October 2015.
  6. ^ Lu Stout, Kristie. "Meet China's 1%: The billionaires in Beijing's halls of power". edition.cnn.com/. CNN. Retrieved 22 October 2015.
  7. ^ Hoogewerf, Richard. "Who are China's 'vampire' billionaires?". money.cnn.com/. CNN. Retrieved 22 October 2015.
  8. ^ Branigan, Tania. "Politburo, army, casinos: China's corruption crackdown spreads". Theguardian.com. The Guardian UK. Retrieved 22 October 2015.
  9. ^ "Yangtze River Pharmaceutical(Group) Co.,". CPhI SEA | Bangkok is Calling. 2019-01-11. Retrieved 2019-12-19.
  10. ^ Corporation, ShangPharma. "ShangPharma Corporation Announces Completion of Merger". www.prnewswire.com. Retrieved 2019-12-19.
  11. ^ "ShangPharma Announces Second Milestone in Move to Enter Chinese Capital Market". ChemPartner.com. 2017.{{cite web}}: CS1 maint: url-status (link)
  12. ^ "How this Chinese biotech player is building and boosting a network of startups". www.bizjournals.com. Retrieved 2019-12-19.{{cite web}}: CS1 maint: url-status (link)
  13. ^ "ShangPharma Innovation Incubator Expansion Is Taking Strong Root in the Bay Area". BioSpace. Retrieved 2019-12-19.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Xu_Jingren&oldid=970965021"